# FDA Inspection 1121903 - Bloodworks - March 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/7f5d0abc-4b4d-49a2-a270-695f2ecdb211
Source feed: FDA_Inspections

> FDA Inspection 1121903 for Bloodworks on March 12, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121903
- Company Name: Bloodworks
- Inspection Date: 2020-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1310040 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/bloodworks/06abd104-95e2-401d-8a74-8e9c620ac7b8)
- [FDA Inspection 1310040 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/bloodworks/fd61a29e-06d7-4fd5-9f38-b938ca5acab6)
- [FDA Inspection 1121903 - 2020-03-12](https://www.keypedia.com/records/fda_inspections/bloodworks/7286f102-1425-4467-804a-255de154d627)
- [FDA Inspection 1035495 - 2017-12-20](https://www.keypedia.com/records/fda_inspections/bloodworks/5ade7908-b619-4c40-8a4c-f54b2008d3ac)
- [FDA Inspection 946892 - 2015-10-21](https://www.keypedia.com/records/fda_inspections/bloodworks/1fa3aef3-9c56-4b37-a7d5-5f0bd425a1a0)

Company: https://www.keypedia.com/companies/bloodworks/4de6239f-ff73-49bf-a813-9fd4b3bd8b50

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d